P08.03â Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy
Pilard, C, Roncarati, P, Hendrick, E, Lebeau, A, Bruyère, D, Lerho, T, Ancion, M, Reynders, C, Delvenne, P, Herfs, M, Hubert, PVolume:
8
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1136/jitc-2020-itoc7.99
Date:
October, 2020
File:
PDF, 82 KB
2020